Trellis Bioscience
trellisbio.com
Actively hiring
Biologics & Biosimilars
Health Care
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$6.1M
1 round on record
Latest round
$6.1M
Venture round · Jan 2026 · 8 mo ago
Backers
1
AMR Action Fund
The money's age
Fresh money
8 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 30
Raised a round Venture round $6.1M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jan 2026 | $6.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Trellis Bioscience, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Stefan RyserExecutive OfficerSEC Form D
Geoff DillonExecutive OfficerSEC Form D
Larry KauvarExecutive OfficerSEC Form D
Elisabeth WhitneyExecutive OfficerSEC Form D
Nora MendeExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
AMR Action Fund Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse…
Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) to address the hallmarks of cancer lethality.
Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a…
Neurolieve Biosciences is developing NLV-01, a first-in-class, non-opioid biologic designed to silence neuropathic pain and trigger…
Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting…
Lipum is a biopharmaceutical company specialized on a novel way to treat chronic inflammatory diseases.
People
Stefan Ryser
Executive Officer
Geoff Dillon
Executive Officer
Larry Kauvar
Executive Officer
Elisabeth Whitney
Executive Officer
Nora Mende
Executive Officer
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Redwood City
United States
HQ
702 Marshall St, Redwood City, California 94063, US
702 Marshall St, Redwood City, California 94063, US
Financials
Total raised
$6.1M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $6.1M | Details |